Amanta Healthcare (AMANTA) — Annual Report

📢 Key Event
AGM scheduled for September 16, 2026, with director remuneration revisions and re-appointment of directors

🔄 What Changed
Debt-to-equity ratio improved from 3x to 1.06x; PAT grew 42% YoY to ₹15 crores; EBITDA margin stable at 22%; ₹130 crores FY26 capex announced

🔮 What's Next
SteriPort capacity to scale from 6.6 to 12 crore bottles annually; 10.8 MW solar project to reduce power costs from FY26-27; capex of ₹130 crores in FY26 and ₹25 crores in FY27

💡 Investor Takeaway
Strong financial growth with improved profitability and debt reduction, but capex-driven expansion requires monitoring of execution and ROI

Amanta Healthcare Limited announced its 31st AGM on September 16, 2026, via video conferencing, with e-voting from September 13-15, 2026, and a cut-off date of September 9, 2026. The filing details shareholder participation protocols, including remote access via CDSL platforms and restrictions on proxy voting. It also discloses director remuneration revisions for Managing Director Bhavesh Girishbhai Patel effective April 1, 2026, with a proposed annual package of up to ₹160 lakhs, and re-appointment of Non-Executive Director Nimesh P Patel. The company highlighted its financial performance, including ₹288 crores revenue (5% growth), ₹63 crores EBITDA (22% margin), and ₹15 crores PAT (42% YoY growth), alongside a debt-to-equity ratio improvement from 3x to 1.06x. Strategic updates include ₹130 crores FY26 capex for capacity expansion, a 10.8 MW solar project to reduce power costs from FY26-27, and SteriPort capacity scaling from 6.6 to 12 crore bottles annually. The filing confirms no subsidiaries, no material regulatory actions, and compliance with ESG norms, including 38.2% female workforce representation and ₹28.72 lakhs CSR spend.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMANTA ✨ Ask AI About This

About Amanta Healthcare Limited (AMANTA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹726.89 Cr P/E: 45.0 ROE: 15.2% ROCE: 14.1%

View full AMANTA stock details →

📡 Get AI alerts when AMANTA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMANTA — Free

💡 Ask AI about this filing

"How will the ₹130 crore FY26 capex be allocated across SteriPort, SVP, and solar projects?" "What is the expected ROI timeline for the SteriPort expansion to 12 crore bottles?" "How will the 10.8 MW solar project impact power cost savings and profitability from FY26-27?"

Ask AI Free →

📊 More AMANTA filings

See all AMANTA filings →

🔥 Also filed on 24 August 2026

BALAJITELE Balaji Telefilms Limited Corporate Action PATINTLOG Patel Integrated Logistics Limited Corporate Action SKIL SKIL Infrastructure Limited Announcement RHL Robust Hotels Limited Annual Report AAVAS Aavas Financiers Limited Annual Report CTE Cambridge Technology Enterprises Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMANTA files new disclosures

Track AMANTA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AMANTA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd